bioAffinity Technologies, Inc. (BIAF)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Laboratory Services	2.51M
Diagnostic Research and Development	19.44K
CyPath Lung Flow Cytometry Test	-

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
United States	2.53M
United States Growth	52627.44%